CVR: 44074214
Incipiam Pharma ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Casper Tind Hansen. The company's owners include MTC 2008 HOLDING ApS, CTH Holding Invest ApS and Bondo Hansen Holding ApS. In 2025, the company reported a gross profit of DKK -1,201,246 and a net result of DKK -1,847,358. Equity amounted to DKK -1,948,853.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at udføre aktiviteter relaterede til forskning og udvikling rettet mod fremstilling og kommercialisering af lægemidler inden for cardio-metabolske sygdomme og andre sygdomstilstande, og andre med lægemiddel-udvikling relaterede aktiviteter, samt at yde konsulentydelser til selskaber, som er beskæftigede indenfor selskabets hovedformål.
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.054 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Contact info changed: new phone: 42720470, new email: [email protected] (March 30, 2026).
Incipiam Pharma ApS has published its annual report for 2025. Gross profit came to DKK -1,201,246, and the net result was DKK -1,847,358.
As of March 27, 2026, EY Godkendt Revisionspartnerselskab has been appointed auditor of Incipiam Pharma ApS.
Address changed to Ottiliavej 9 9, 2500 Valby (February 22, 2026).
Contact info changed: new phone: 42720470, new email: [email protected] (February 22, 2026).
Incipiam Pharma ApS has published its interim report for the period January 1, 2024 – September 30, 2024.
Incipiam Pharma ApS has published its interim report for the period May 23, 2023 – December 31, 2023.
As of May 23, 2023, Casper Tind Hansen is registered as adm. dir. of Incipiam Pharma ApS.
As of May 23, 2023, MTC 2008 HOLDING ApS is registered as an owner of Incipiam Pharma ApS with an ownership share of 20%.
As of May 23, 2023, CTH Holding Invest ApS is registered as an owner of Incipiam Pharma ApS with an ownership share of 20%.
As of May 23, 2023, Bondo Hansen Holding ApS is registered as an owner of Incipiam Pharma ApS with an ownership share of 20%.
As of May 23, 2023, Gerhart-Hines Holding ApS is registered as an owner of Incipiam Pharma ApS with an ownership share of 20%.
As of May 23, 2023, Receptor Holding ApS is registered as an owner of Incipiam Pharma ApS with an ownership share of 10%.
Incipiam Pharma ApS was founded on May 23, 2023.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 40766383
CVR 42731323
CVR 38599119
companydata.dk